首页> 外文会议>Bioinformatics and Biomedical Engineering , 2009. ICBBE 2009 >Hypolipidemic Effect and Safety of Ursolic Acid Glycoside Esters
【24h】

Hypolipidemic Effect and Safety of Ursolic Acid Glycoside Esters

机译:熊果糖苷苷的降血脂作用和安全性

获取原文
获取外文期刊封面目录资料

摘要

To investigate the effect of ursolic acid glycoside esters (UAGE) on blood lipid of animal and its acute toxicity, UAGE was synthesized and its hHypolipidemic effect was studied. ICR mice were used to build the model of hyperlipoidemia. The ursolic acid glucose ester was feed to the test animal to study the effect of hypolipidemic effect by measurement of the index of total cholesterol (TC), triglyceride (TG) and high density lipoprotein cholesterol (HDL-c). The acute toxicity of UAGE on mice was also observed. The results shown that UAGE remarkably decreased the serum TC, TG and increased the serum HDL-c of mices. The virtually non-toxic dose of UAGE in mice was less than 25 g/kg .This shown that ursolic acid glucose ester has the function of hypolipidemic effect and has higher safety. It could be developed a new function food components.
机译:为了研究熊果糖苷酯(UAGE)对动物血脂的影响及其急性毒性,合成了UAGE并研究了其降血脂作用。使用ICR小鼠建立高脂血症模型。将熊果糖酸葡萄糖酯喂入试验动物以通过测量总胆固醇(TC),甘油三酸酯(TG)和高密度脂蛋白胆固醇(HDL-c)的指数来研究降血脂作用。还观察到UAGE对小鼠的急性毒性。结果表明,UAGE显着降低了小鼠的血清TC,TG和增加了血清HDL-c。小鼠中UAGE的几乎无毒剂量低于25 g / kg。这表明熊果酸葡萄糖酯具有降血脂作用,并且具有更高的安全性。可以开发一种新功能的食品成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号